Tag: Amplatzer Amulet
AHA 2024: Five-year Amulet IDE data show similar outcomes with Amplatzer and Watchman devices
Latest data from the Amulet investigational device exemption (IDE) trial, comparing the Amplatze...
TCT 2022: Amulet occluder keeps pace with Watchman at three years
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...
PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high imp...
PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, ma...
TCT 2016: High implant success rates with St Jude Medical’s Amulet LAA occluder
A study presented at the last late-breaking trial session of the 2016 Transcatheter Cardiovascul...
St Jude Medical launches trial of Amplatzer Amulet left atrial appendage occluder
The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will ev...
